References
- Wright AE, Morgan WP, Colebrook L, Dodgson RW. Observations on prophylactic inoculation against pneumococcus infections, and on the results which have been achieved by it. Lancet 1914; i: 1–10,87-95
- Lister FS. An experimental study of prophylactic inoculation against pneumococcal infection in the rabbit and in man. Publ South Afr Inst Med Res 1916; 8: 231–287
- Macleod CM, Hodges RG, Heidelberger M, Bernhard WG. Prevention of pneumococcal pneumonia by immunization with specific capsular polysaccharides. J Exp Med 1945; 82: 445–465
- Austrian R, Douglas RM, Schiffman G, et al. Prevention of pneumococcal pneumonia by vaccination. Trans Assoc Am Physicians 1976; 89: 184–194
- Smit P, Oberholzer D, Hayden-Smith S, Koornhof HJ, Hilleman MR. Protective efficacy of pneumococcal polysaccharide vaccines. JAMA 1977; 238: 2613–2616
- Huss A, Scott P, Stuck AE, Trotter C, Egger M. (2009) Efficacy of pneumococcal vaccination in adults: a meta-analysis. Canadian Med Assoc J 2009; 180: 48–58
- Cutts FT, Zaman SM, Enwere G, et al. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. Lancet 2005; 365: 1139–1146
- Hansen J, Black S, Shinefield H, et al. Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than 5 years of age for prevention of pneumonia: updated analysis using World Health Organization standardized interpretation of chest radiographs. Pediatr Infect Dis J 2006; 25: 779–781
- Klugman KP, Madhi SA, Huebner RE, et al. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N Engl J Med 2003; 349:1341–1348
- Lucero MG, Nohynek H, Williams G, et al. Efficacy of an 11-valent pneumococcal conjugate vaccine against radiologically confirmed pneumonia among children less than 2 years of age in the Philippines: a randomized, double-blind, placebo-controlled trial. Pediatr Infect Dis J 2009; 28: 455–462
- Klugman KR (2001) Efficacy of pneumococcal conjugate vaccines and their effect on carriage and antimicrobial resistance. Lancet Infect Dis 2001; 1: 85–91
- Lennette EH, Spaulding EH, Truant JR Manual of Clinical Microbiology. Washington, D.C.: ASM Press, 1974
- Ridda I, Macintyre CR, Lindley R, et al. Lack of pneumococcal carriage in the hospitalised elderly. Vaccine 28: 3902-3904
- Mackenzie GA, Leach AJ, Carapetis JR, Fisher J, Morris PS. Epidemiology of nasopharyngeal carriage of respiratory bacterial pathogens in children and adults: cross-sectional surveys in a population with high rates of pneumococcal disease. BMC Infect Dis 10:304
- Nuorti JP, Butler JC, Crutcher JM, et al. An outbreak of multidrug-resistant pneumococcal pneumonia and bacteremia among unvaccinated nursing home residents. N Engl J Med 1998; 338:1861–1868
- Riley ID, Tarr PI, Andrews M, et al. Immunisation with a polyvalent pneumococcal vaccine. Reduction of adult respiratory mortality in a New Guinea Highlands community. Lancet 1977; 1:1338–1341
- Douglas RM, Hansman D, Miles HB, Paton JC. Pneumococcal carriage and type-specific antibody. Failure of a 14-valent vaccine to reduce carriage in healthy children. Am J Dis Child 1986; 140:1183–1185
- Al meidaV de C, Negrini BV, Cervi MC, Isaac Mde L, Mussi-Pinhata MM. Pneumococcal nasopharyngeal carriage among infants born to human immunodeficiency virus-infected mothers immunized with pneumococcal polysaccharide vaccine during gestation. Pediatr Infect Dis J 30: 466–470.
- Makela PH, Kayhty H. Vaccine - induced immunity to pneumococcal infection. In: Tuomanen E, Mitchell G, Morrison DA, Spratt BG, eds. The pneumocccus. Washington, D.C.: ASM Press, 2004: 403–420
- Prymula R, Peeters P, Chrobok V, et al. Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study. Lancet 2006; 367: 740–748